D. E. Shaw & Co., Inc. Rafael Holdings, Inc. Transaction History

D. E. Shaw & Co., Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.65 - $2.82 $31,607 - $54,019	-19,156 Reduced 19.82%	77,474 $145,000
Q1 2022 May 16, 2022	BUY	$2.1 - $5.23 $202,923 - $505,374	96,630 New	96,630 $243,000
Q1 2020 May 15, 2020	SELL	$10.4 - $22.58 $108,711 - $236,028	-10,453 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$15.46 - $21.5 $64,359 - $89,504	-4,163 Reduced 28.48%	10,453 $186,000
Q3 2019 Nov 14, 2019	SELL	$18.83 - $27.01 $73,474 - $105,393	-3,902 Reduced 21.07%	14,616 $306,000
Q2 2019 Aug 14, 2019	SELL	$12.3 - $28.75 $11,820 - $27,628	-961 Reduced 4.93%	18,518 $532,000
Q1 2019 May 15, 2019	SELL	$8.29 - $18.49 $819,425 - $1.83 Million	-98,845 Reduced 83.54%	19,479 $246,000
Q4 2018 Feb 14, 2019	SELL	$7.63 - $9.1 $55,851 - $66,612	-7,320 Reduced 5.83%	118,324 $938,000
Q3 2018 Nov 14, 2018	SELL	$8.4 - $10.17 $7,408 - $8,969	-882 Reduced 0.7%	125,644 $1.06 Million
Q2 2018 Aug 14, 2018	BUY	$4.55 - $10.11 $203,726 - $452,675	44,775 Added 54.77%	126,526 $1.16 Million
Q1 2018 May 15, 2018	BUY	$4.65 - $4.9 $380,142 - $400,579	81,751 New	81,751 $397,000

2.1M

Ticker RFL
Exchange NYSE
Sector Real Estate
Industry Real Estate Services
Shares Outstandng 23,242,200
Market Cap $48.1M
Description
Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and develo...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.